Search the website | European Medicines Agency

Search the website

Use this page to find content on this website. For help on how to get the results you want, see our search tips.

Search results

Categories

Type of content

Documents Remove Documents filter News Remove News filter Events Remove Events filter

Document type

Open for consultation

Document reference number

Consultation start date (≥ to)

Consultation end date (≤ to)

Topic

Responsible body

Last updated

First published

6 results

Sort by

List item

Draft 2 - Lapatinib film-coated tablet 250 mg product-specific bioequivalence guidance (PDF/149.33 KB)

Draft: consultation open
First published: 03/07/2020
Last updated: 17/11/2020
Consultations dates: from 06/07/2020 to 31/01/2021
EMA/CHMP/257298/2018
List item

Draft acenocoumarol, tablet, 1 mg and 4 mg product-specific bioequivalence guidance - First version (PDF/139.48 KB)

Draft: consultation open
First published: 09/11/2020
Consultations dates: from 09/11/2020 to 28/02/2021
EMA/CHMP/512475/2020
List item

Palbociclib hard capsule 75 mg, 100 mg and 125 mg and film-coated tablet 75 mg, 100 mg and 125 mg product-specific bioequivalence guidance - Revision 1 (PDF/160.42 KB)

Draft: consultation open
First published: 23/11/2020
Consultations dates: from 23/11/2020 to 28/02/2021
EMA/CHMP/472421/2020/Rev. 1
List item

Draft guideline on the evaluation of anticancer medicinal products in man - Revision 6 (PDF/538.16 KB)

Draft: consultation open
First published: 16/11/2020
Consultations dates: from 13/11/2020 to 15/02/2021
EMA/CHMP/205/95 Rev.6
List item

ICH reflection paper on proposed ICH guideline work to advance patient focused drug development (PDF/294.38 KB)

Draft: consultation open
First published: 10/12/2020
Consultations dates: from 10/12/2020 to 07/03/2021
EMA/CHMP/ICH/415588/2020
List item

Deferasirox, dispersible tablets (125 mg, 250 mg and 500 mg), film-coated tablets (90 mg, 180 mg, and 360 mg), and granules (90 mg, 180 mg and 360 mg) product-specific bioequivalence guidance (PDF/175.22 KB)

Draft: consultation open
First published: 18/12/2020
Consultations dates: from 18/12/2020 to 31/03/2021
EMA/CHMP/472383/2020